Charles M. Lieber
Charles M. Lieber
Charles M. Lieber
Charles M. Lieber
Charles M. Lieber
Charles M. Lieber
Charles M. Lieber
Charles M. Lieber
Charles M. Lieber
Charles M. Lieber
Charles M. Lieber
Charles M. Lieber
Charles M. Lieber
Charles M. Lieber
Charles M. Lieber
Charles M. Lieber
Charles M. Lieber
Charles M. Lieber
Charles M. Lieber
Charles M. Lieber
Institute of Virology, Wuhan, China
Funding
Bill & Mellinda Gates Foundation, Collaboration on AIDS Vaccine Discovery (CAVD) (OPP1040727) „Induction of affinity-matured HIV Env antibodies in the absence of HIV specific T helper cells".
EU, European AIDS vaccine initiative 2020 (EAVI 2020).
Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg, Project J69.
Collaborations
Prof. Dr. Dennis Burton, The Scripps Research Institute, La Jolla, USA
Prof. Dr. Matthias Epple, Institute of Inorganic Chemistry, Essen, Germany
Dr. Dietmar Katinger, Polymun Scientific Immunbiologische Forschung GmbH, Bad Klosterneuburg, Austria
Dr. Christiane Stahl-Hennig, Unit of Infection Models at the German Primate Center, Göttingen, Germany
Prof. Rich Wyatt, The Scripps Research Institute, La Jolla, USA
Prof. Dr. Huimin Yan, Institute of Virology, Wuhan, China
https://www.virologie.uk-erlangen.de/en/research/research-groups/research-group-of-k-ueberlak-nganou/funding-and-collaborations/
Welcome Back General Flynn